Ares Capital Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARCC research report →
Range $19 – $19
Price Chart
About the company
Ares Capital Corporation (ARCC) operates as a Business Development Company (BDC), delivering diverse financing solutions predominantly to middle-market enterprises. The firm's expertise lies in facilitating various corporate actions, including funding acquisitions, recapitalizations, and leveraged buyouts. It also extends mezzanine debt, assists with corporate restructurings, and provides crucial rescue financing, in addition to offering growth capital and general refinancing options.
- CEO
- Kort Schnabel
- IPO
- 2004
- Employees
- 4,250
- HQ
- Los Angeles, CA, US
Get TickerSpark's AI analysis on ARCC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.22B
- P/E
- 14.67
- Fwd P/E
- 10.39
- PEG
- -0.43
- P/S
- 6.15
- P/B
- 1.02
- EV/EBITDA
- 18.14
- Div Yield
- 9.70%
- Gross Margin
- 67.04%
- Op Margin
- 62.93%
- Net Margin
- 41.52%
- ROE
- 6.78%
- ROIC
- 1526.49%
Latest fiscal year · YoY change
- Revenue
- $2.24B-5.3%
- Gross Profit
- $1.51B-11.8%
- Op Income
- $1.40B
- Net Income
- $1.30B-14.7%
- EPS
- $1.86-23.8%
- OCF Growth
- -10.9%
- FCF Growth
- -10.9%
- 52W High
- $22.53
- 52W Low
- $17.40
- 50D MA
- $18.93
- 200D MA
- $19.31
- Beta
- 0.62
- RSI (14)
- 58
- Avg Volume
- 4.85M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Ares Capital said second-quarter core earnings were steady, credit performance remained healthy, and stronger market conditions plus improved funding options left it well positioned despite a softer deal environment.· July 29, 2026
- Core EPS was $0.47, flat with the prior quarter, while GAAP EPS rose to $0.24 from $0.13.
- NAV ended at $19.35 per share, down $0.24 sequentially, and leverage was stable at 1.12x debt-to-equity net of cash.
- Portfolio health remained solid: non-accruals at cost were 2.4%, organic weighted average LTM EBITDA growth was about 8%, and the company cited equity cushions of more than 50% beneath investments.
- Investment activity improved late in the quarter: ARCC reviewed more than 25% more transactions than the prior quarter, with 75% of transactions with incumbent borrowers.
- Management highlighted balance-sheet strength, including about $6 billion of available liquidity, no unsecured note maturities in 2026, and only $1.4 billion maturing in 2027.
Ares Capital reported GAAP net income per share of $0.24, up from $0.13 in the first quarter of 2026. Core earnings were $0.47 per share, consistent with the prior quarter, and management said that implied an annualized return on equity of 9.7%. Net asset value ended at $13.9 billion, or $19.35 per share, down $0.24 per share quarter over quarter. The portfolio was $29.3 billion at fair value, down slightly from $29.5 billion in the first quarter, and leverage was 1.12x debt-to-equity net of available cash. Management said available liquidity was approximately $6 billion, with no additional unsecured note maturities in 2026 and $1.4 billion maturing in 2027. For the third quarter of 2026, the regular dividend is $0.48 per share, payable September 30 to stockholders of record September 15. Management also estimated approximately $988 million, or $1.38 per share, of taxable spillover income available for future periods. Forward-looking commentary was constructive but cautious: management expects transaction activity to improve, sees leverage with some room to move within its 0.9x to 1.25x target range, and said the current regular dividend remains appropriate for long-run earnings power.
Kort Schnabel framed the quarter as solid, emphasizing stable core earnings, healthy portfolio performance, and a stronger setup for future originations. He repeatedly stressed ARCC’s scale, diversified capital base, and incumbent borrower relationships, saying those advantages are drawing more opportunities as competitors backed by retail capital become less active. His tone was confident but disciplined: he said ARCC remains highly selective, is not chasing volume, and views the current dividend as well supported by earnings, spillover income, and credit performance.
Scott Lem focused on stable earnings, balance-sheet strength, and funding efficiency. He cited GAAP net income per share of $0.24, core EPS of $0.47, NAV of $19.35 per share, leverage of 1.12x, and about $6 billion of available liquidity. He also highlighted roughly $1.2 billion of additional financing during the quarter, the new $1 billion commercial paper program that could lower funding costs by about 50 to 100 basis points versus average secured borrowings, and the post-quarter reset of the $476 million debt securitization that cut the spread by 35 basis points while extending reinvestment and final maturity. He reiterated the third-quarter dividend of $0.48 and said taxable spillover income is about $988 million, or $1.38 per share.
Analysts pressed management on whether industry weakness and dispersion could create M&A or strategic acquisition opportunities, and Kort said the likelihood of such a transaction is probably higher than in the past, while declining to discuss specific alternatives. Questions also focused on industry credit normalization, prepayments, PIK usage, the commercial paper program, and two troubled names; management mostly answered at a market level, saying non-accruals are trending toward historical norms because portfolios are maturing and that it is not seeing a specific industry trend driving ARCC’s new non-accruals. On the two challenged credits, management would not comment on names but said it is in ongoing and constructive dialogue with the sponsor and has some confidence in addressing near-term maturities.
The positive case from the call is that ARCC appears to be taking share in a more selective market, with more than 25% more transactions reviewed than last quarter and 75% of deals with existing borrowers. Management said deal terms improved, the portfolio remains diversified and healthy, and the balance sheet is fortified by about $6 billion of liquidity, a well-laddered maturity schedule, and cheaper funding options.
The main risks discussed were a softer transaction backdrop, more cautious deal quality, and ongoing normalization in industry credit metrics. Management acknowledged some weak names and said non-accruals across the industry should trend back toward historical norms, which implies more pressure may remain as portfolios mature. They also noted NAV declined modestly and that deal flow can be hampered by rate volatility and by competition in certain parts of the market.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.4%
- Shares Outstanding
- 718.02M
- Float Shares
- 713.78M
of shares held by institutions
833 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ARCC, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Pete SessionsHouse · TX17 | Sell | Jul 24, 26 | Filing → |
| John FettermanSenate · PA | Buy | Sep 9, 25 | Filing → |
| John FettermanSenate · PA | Sell | Sep 4, 25 | Filing → |
| Ashley MoodySenate | Buy | Apr 4, 25 | Filing → |
| John FettermanSenate · PA | Buy | Feb 18, 25 | Filing → |
| Pete SessionsHouse · TX17 | Sell | Nov 1, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Oct 6, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Oct 6, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Aug 15, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Aug 15, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Jul 14, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Jul 14, 23 | Filing → |
| Zoe LofgrenHouse · CA18 | Sell | May 25, 23 | Filing → |
| Thomas R. CarperSenate · DE | Sell | Jan 18, 22 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 17.02M | ▲ 668.63K |
| Ubs Group AG | 13.78M | ▼ 537.74K |
| Van Eck Associates Corp | 13.31M | ▲ 2.42M |
| Strs Ohio | 10.66M | ▲ 157.09K |
| Bank Of America Corp | 8.94M | ▼ 200.26K |
| Jpmorgan Chase & Co | 7.85M | ▲ 156.11K |
| Generali Asset Management Spa Sgr | 7.55M | 0 |
| Legal & General Group PLC | 6.51M | ▲ 535.29K |
| Two Sigma Investments, LP | 5.89M | ▼ 1.42M |
| Wells Fargo & Company/Mn | 4.44M | ▼ 49.50K |
| Ameriprise Financial Inc | 4.12M | ▲ 346.23K |
| Lpl Financial LLC | 4.03M | ▼ 9.04K |
Held by 57 ETFs
Biggest fund positions in ARCC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 9, 26 | MARKOWICZ JANA | buy | 15,000 |
| Feb 6, 26 | Lem Scott C | buy | 5,186 |
| Feb 5, 26 | HENSON MARY BETH | buy | 4,000 |
| Feb 5, 26 | SCHNABEL MICHAEL KORT | buy | 12,500 |
| Oct 31, 25 | SCHNABEL MICHAEL KORT | buy | 13,000 |
| Sep 30, 25 | Fitzgerald Ian | other | 0 |
| Oct 24, 24 | Miller James Robert | other | 0 |
| Mar 3, 25 | Miller James Robert | buy | 40,000 |
| Feb 18, 25 | Arougheti Michael J | other | 300,172 |
| Feb 11, 25 | Bates Ann Torre | buy | 6,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ARCC coverage
Recent articles, reports, and earnings notes.

The Best Private Credit Stocks Right Now (Updated June 2026)
Seven private credit stocks ranked by investment quality — Blackstone Secured Lending, Golub, and Main Street Capital all place, while the top two spots close out the countdown.

Nuveen Investment Funds IPO: The Bull and Bear Case
Nuveen Investment Funds, Inc. (NGIF) is expected to list on the NYSE on 2026-06-03, but the price range has not been disclosed. The setup is less a classic IPO and more a fund offering tied to infrastructure exposure. Bull case: a long Nuveen track record and a specialized mandate; bear case: this is not an operating company IPO, and the filing set does not show traditional growth metrics.

Stellus Capital Investment Corporation 5.75% NT 2022: Private Credit Story
Stellus Capital Investment Corporation 5.75% NT 2022 is expected to list on NASDAQ on 2026-05-27, but the price range has not been disclosed. The security appears to be a notes issue, not a new equity IPO, so the key question is how investors view the company’s private credit funding model. Watch the structural-subordination risk and the fact that Stellus has already been public since 2012.
Want a deeper read on ARCC?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
If You'd Invested $10,000 in Each of These 3 High-Yield Stocks 10 Years Ago, Here's How Much Income You'd Collect Today
fool.com · Aug 20
Ares Capital Has Maintained or Raised Its Dividend for Over 16 Years. Here's What That Streak Is Built On.
fool.com · Aug 19
The Dividend Winners and Losers From 5% Treasury Yields
247wallst.com · Aug 19
3 High-Yield Dividend Stocks I'd Buy With $5,000 Right Now
fool.com · Aug 19
The BDC Asymmetry That Nobody Prices In
seekingalpha.com · Aug 17
2 BDCs To Sell Before The Dividend Cuts Land
seekingalpha.com · Aug 16
The Russell 2000 Hits All-Time High: 4 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist
247wallst.com · Aug 14
These 4 Dividend Stocks Yield 8%. Only Roth Owners Keep All of It
247wallst.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.